Comparative effects of conventional hormone replacement therapy and tibolone on climacteric symptoms and sexual dysfunction in postmenopausal women.
Phase of Trial: Phase III
Latest Information Update: 01 Sep 2016
At a glance
- Drugs Tibolone (Primary) ; Conjugated estrogens/medroxyprogesterone
- Indications Menopausal syndrome
- Focus Therapeutic Use
- 25 Aug 2011 Actual initiation date (22 Dec 2006) added and additional lead trial centre identified as reported by Iranian Registry of Clinical Trials.
- 25 Aug 2011 New source identified and integrated (Iranian Registry of Clinical Trials; IRCT138809032766N1).
- 05 Nov 2010 New trial record.